Clinical trial
A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on…
NCT00283465 · Janssen-Cilag B.V., Industry · Completed
Key facts
| NCT number | NCT00283465 |
|---|---|
| Title | A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chemotherapy |
| Official title | An Open-label, Randomized Study to Evaluate the Effect of Early Treatment of Anemia With Epoetin Alfa on Hemoglobin, the Incidence of Blood Transfusions and Quality of Life in Patients Receiving Platinum-containing Chemotherapy |
| Lead sponsor | Janssen-Cilag B.V., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Anemia, Neoplasm |
| Intervention type | Drug |
| Interventions | Epoetin alfa |
| Enrollment | 316 |
| Start date | Nov 1, 1999 |
| Completion | Apr 1, 2004 |
| First posted | Jan 30, 2006 |
| Last update posted | Jan 14, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: